# Healthpoint clinical trials: 34 on ClinicalTrials.gov (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 34 trials with Healthpoint as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Healthpoint: 34 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/healthpoint

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 34
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 34, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| June 3, 2014 | NCT02154087 | A Phase 2 Exploratory Pharmacodynamic Study of HP802-247 in Venous Leg Ulcers | Healthpoint | Phase 2 | Terminated | Venous Leg Ulcers | 1 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02154087) |
| April 11, 2014 | NCT02111291 | Santyl Applications to Diabetic Foot Ulcers | Healthpoint | Phase 4 | Completed | Diabetic Foot Ulcers, Diabetic Foot Wounds | 215 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02111291) |
| October 28, 2013 | NCT01970657 | Observational Study Providing 12 Months of Safety Follow-Up From First Exposure to HP802-247 | Healthpoint | Observational | Completed | Venous Leg Ulcer (VLU) | 221 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01970657) |
| May 15, 2013 | NCT01853384 | Safety and Efficacy Trial of HP802-247 in the Treatment of Chronic Venous Leg Ulcers | Healthpoint | Phase 3 | Terminated | Venous Ulcer, Venous Stasis Ulcer, Ulcer | 252 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01853384) |
| April 18, 2013 | NCT01835379 | Study of Oasis Ultra in Diabetic Foot Ulcers | Healthpoint | Phase 4 | Completed | Diabetic Foot Ulcer | 82 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01835379) |
| November 30, 2012 | NCT01737762 | Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers \>12 cm2 to ≤ 36 cm2 | Healthpoint | Phase 3 | Completed | Venous Leg Ulcers | 155 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01737762) |
| October 12, 2012 | NCT01705860 | Long Term Follow Up to Determine the Effects of Collagenase SANTYL Ointment on Scar Formation | Healthpoint | Observational | Completed | Follow up to Acute Wound Scar Study | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01705860) |
| August 7, 2012 | NCT01658618 | Safety Study Providing 12 Months Follow-up From First Exposure to HP802-247 in Subjects With Venous Leg Ulcer | Healthpoint | Observational | Unknown | Venous Leg Ulcer | 440 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01658618) |
| August 3, 2012 | NCT01656889 | Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers | Healthpoint | Phase 3 | Completed | Venous Leg Ulcers | 447 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01656889) |
| February 8, 2012 | NCT01528306 | A Pilot Study of HP802-247 in Dystrophic Epidermolysis Bullosa | Healthpoint | Phase 2 | Withdrawn | Dystrophic Epidermolysis Bullosa | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01528306) |
| January 24, 2012 | NCT01516463 | Using Santyl or Bacitracin on Second Degree Burns | Healthpoint | Phase 4 | Withdrawn | Burn, Partial Thickness | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01516463) |
| September 13, 2011 | NCT01433159 | Comparison of HP011-101 to Standard Care for Stage I-II Pressure Ulcers in Subjects With Spinal Cord Injury | Healthpoint | Phase 2 | Terminated | Pressure Ulcers, Spinal Cord Injury | 19 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01433159) |
| August 3, 2011 | NCT01408277 | Using Santyl on Diabetic Foot Ulcers | Healthpoint | Phase 4 | Completed | Diabetic Foot Ulcers, Diabetic Foot Wounds | 55 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01408277) |
| May 25, 2011 | NCT01359735 | Healing Effects of HP802-247 Versus Antibiotic Ointment in Mohs Micrographic Surgery Patients | Healthpoint | Phase 2 | Completed | Non-melanoma Skin Cancer | 8 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01359735) |
| January 10, 2011 | NCT01273428 | HP011-101, HP828-101, and Standard Care for Pressure Ulcers | Healthpoint | Phase 2 | Withdrawn | Pressure Ulcers | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01273428) |
| December 3, 2010 | NCT01253135 | Study to Determine if Fibrin Affects the Ability of a Wound to Heal | Healthpoint | Phase 1 | Completed | Effect of Test Articles on the Healing of a Wound Artificially Induced by Liquid Nitrogen Spray | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01253135) |
| September 9, 2010 | NCT01197898 | Wound Edge Changes Following Treatment With Santyl | Healthpoint | Phase 4 | Completed | Diabetic Foot Ulcers, Diabetic Foot Wounds | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01197898) |
| August 30, 2010 | NCT01190865 | Study of Survival Duration for Donor Skin Cells in Skin Biopsy Wounds | Healthpoint | Phase 1 | Completed | Normal Female Volunteers | 28 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01190865) |
| June 14, 2010 | NCT01143727 | Enzymatic Versus (vs) Autolytic Debridement of Diabetic Foot Ulcers | Healthpoint | Phase 4 | Completed | Diabetic Foot Ulcers | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01143727) |
| June 14, 2010 | NCT01143714 | A Study to Look at the Effects of Four Weeks of Treatment on the Healing of Diabetic Foot Ulcers | Healthpoint | Phase 4 | Completed | Diabetic Foot Ulcers | 57 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01143714) |
| June 2, 2010 | NCT01135290 | Post Treatment Care After Chemical Peel or Laser Resurfacing | Healthpoint | Early phase 1 | Withdrawn | Chemical Peel | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01135290) |
| April 22, 2010 | NCT01108523 | Evaluation of Effects of HP828-101 for Moisture Associated Skin Damage | Healthpoint | Early phase 1 | Terminated | Skin Abnormalities | 7 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01108523) |
| January 26, 2010 | NCT01056198 | Santyl vs. Sharp Debridement of Diabetic Foot Wounds | Healthpoint | Phase 4 | Completed | Diabetic Foot Ulcers, Foot Wounds | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01056198) |
| September 3, 2009 | NCT00971048 | Evaluation of the Effects of HP828-101 Versus Standard of Care in the Management of Partial or Full Thickness Wounds | Healthpoint | Not applicable | Completed | Diabetic Foot Ulcers, Pressure Ulcers | 88 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00971048) |
| May 12, 2009 | NCT00900029 | Safety Follow-Up to HP 802-247-09-015 | Healthpoint | Observational | Completed | Venous Leg Ulcer, Venous Stasis Ulcer | 206 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00900029) |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 2 |
| Phase 1 | 6 |
| Phase 2 | 8 |
| Phase 3 | 3 |
| Phase 4 | 10 |
| Not applicable | 1 |
| Observational | 4 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 24 |
| Withdrawn | 5 |
| Terminated | 4 |
| Unknown | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Varicose Ulcer | 9 |
| Diabetic Foot | 9 |
| Ulcer | 6 |
| Wounds and Injuries | 6 |
| Pressure Ulcer | 3 |
| Cicatrix | 3 |
| Varicose Veins | 2 |
| Venous Insufficiency | 2 |
| Venous Thrombosis | 2 |
| Leg Ulcer | 2 |
| Spinal Cord Injuries | 1 |
| Burns | 1 |
| Skin Abnormalities | 1 |
| Dermatitis, Phototoxic | 1 |
| Diabetes Mellitus | 1 |
| Diabetic Neuropathies | 1 |
| Epidermolysis Bullosa Dystrophica | 1 |
| Epidermolysis Bullosa | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Ski resorts in the United States](https://specstream.ai/data/businesses/ski-resorts/united-states)
- [Surgery practices in the United States](https://specstream.ai/data/businesses/surgery-practices/united-states)
- [Traffic ticketing law firms in the United States](https://specstream.ai/data/businesses/traffic-ticketing-law-firms/united-states)
- [Vietnamese restaurants in the United States](https://specstream.ai/data/businesses/vietnamese-restaurants/united-states)
- [Workers compensation law firms in the United States](https://specstream.ai/data/businesses/workers-compensation-law-firms/united-states)
- [Architectural design firms in the United States](https://specstream.ai/data/businesses/architectural-design-firms/united-states)
